Christos A. Kyratsous, Ph.D.
Affiliations: | 2009 | Columbia University, New York, NY |
Area:
MicrobiologyGoogle:
"Christos Kyratsous"Parents
Sign in to add mentor| Saul Silverstein | grad student | 2009 | Columbia | |
| (The role of chaperone and co-chaperone proteins in alphaherpesvirus replication.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Baum A, Ajithdoss D, Copin R, et al. (2020) REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters. Science (New York, N.Y.) |
| Yurkovetskiy L, Wang X, Pascal KE, et al. (2020) Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant. Cell |
| Simões EAF, Forleo-Neto E, Geba GP, et al. (2020) Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Yurkovetskiy L, Pascal KE, Tompkins-Tinch C, et al. (2020) SARS-CoV-2 Spike protein variant D614G increases infectivity and retains sensitivity to antibodies that target the receptor binding domain. Biorxiv : the Preprint Server For Biology |
| Baum A, Fulton BO, Wloga E, et al. (2020) Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science (New York, N.Y.) |
| Hansen J, Baum A, Pascal KE, et al. (2020) Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science (New York, N.Y.) |
| Cruz JW, Damko E, Modi B, et al. (2019) A novel bispecific antibody platform to direct complement activity for efficient lysis of target cells. Scientific Reports. 9: 12031 |
| Saphire EO, Schendel SL, Fusco ML, et al. (2018) Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection. Cell. 174: 938-952.e13 |
| de Wit E, Feldmann F, Okumura A, et al. (2018) Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets. Antiviral Research |
| Pascal KE, Dudgeon D, Trefry JC, et al. (2018) Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in non-human primates. The Journal of Infectious Diseases |